Systolic Bundle Branch Block, Left

2

Review clinical trials related to Systolic Bundle Branch Block, Left. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing

This 2x2 randomized crossover feasibility study will evaluate the therapeutic value of adding pacing from the left ventricular lead to Left Bundle Branch Area Pacing (LBBAP) using a cardiac resynchronization therapy defibrillator (CRT-D). This combined therapy is known as Left Bundle Branch Optimized Cardiac Resynchronization Therapy (LOT-CRT) and will be compared to LBBAP therapy over sequential 6-month periods in CRT-indicated patients with LBBB. Primary and secondary outcomes are echocardiographic changes. Exploratory assessments will include NT-proBNP and subject-reported quality of life (KCCQ). An observational treatment arm will include subjects who have not been randomized due to unsuccessful implant for real-world observational analysis

Participants needed: 110
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medtronic Cardiac Rhythm and Heart FailureUpdated: Jul 13, 2026
Eligibility criteria

Subject meets current ACC/AHA/HRS guidelines for implantation of a CRT-D device. [+7]

Subject has documented myocardial infarction before enrollment. [+16]

Status: Not yet recruiting

Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing

This 2x2 randomized crossover feasibility study will evaluate the therapeutic value of adding pacing from the left ventricular lead to Left Bundle Branch Area Pacing (LBBAP) using a cardiac resynchronization therapy defibrillator (CRT-D). This combined therapy is known as Left Bundle Branch Optimized Cardiac Resynchronization Therapy (LOT-CRT) and will be compared to LBBAP therapy over sequential 6-month periods in CRT-indicated patients with LBBB. Primary and secondary outcomes are echocardiographic changes. Exploratory assessments will include NT-proBNP and subject-reported quality of life (KCCQ).

Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medtronic Cardiac Rhythm and Heart FailureUpdated: Apr 28, 2026
Eligibility criteria

Subject meets current ACC/AHA/HRS guidelines for implantation of a CRT-D device. [+7]

Subject has documented myocardial infarction before enrollment. [+16]